BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Personalized medicine
,
Trichostatin A
,
rs2230926
,
PRKCA
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphatase shp- 1
Summary
General Info
Curated Studies
Most Correlated Studies
Regulatory T cell expression profiling of shp-1 heterozygous and homozygous knockout BALBc mice.
Mast cells from diabetic prone and diabetic resistant rat strains
Hepatic iNKT cells expressing hCD1d molecule under the pLck promoter
Explore Curated Studies Results
Literature
Most Relevant Literature
The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα …
Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and pho…
Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may con…
Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and s…
Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line…
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Local…
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Stud…
Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma…
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ